OrbiMed Capital GP VII LLC

10% OwnerPassage BIO, Inc. (PASG) · full profile →Form 4 · filed Jan 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$103K
Net Open-Market Flow
-$103K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2025Sell(S)75K$0.68$51K7.3M
Jan 7, 2025Sell(S)53K$0.71$37K7.3M
Jan 6, 2025Sell(S)19K$0.77$15K7.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly: